Craig E. Cole
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 36
- Multiple Myeloma Research and Treatments 35
-
- Protein Degradation and Inhibitors 6
- Cancer therapeutics and mechanisms 5
- Co-authors
- Dennis Pietronigro (6 shared papers)Glen R. Justice (6 shared papers)Jerome B. Zeldis (5 shared papers)Julie M. Vose (5 shared papers)Kenichi Takeshita (5 shared papers)Annette Ervin‐Haynes (5 shared papers)Peter H. Wiernik (5 shared papers)Thomas M. Habermann (3 shared papers)
- Journals
- Blood (22 papers)Journal of Clinical Oncology (8 papers)Blood Cancer Journal (2 papers)Annals of Hematology (1 paper)The American Journal of Medicine (1 paper)
- Partner nations
- United StatesGreeceCanada
In The Last Decade
Craig E. Cole
46 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 64
- Hematology 464
- Genetics 258
- Pathology and Forensic Medicine 403
- Oncology 444
- Molecular Biology 384
Countries citing papers authored by Craig E. Cole
This map shows the geographic impact of Craig E. Cole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig E. Cole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig E. Cole more than expected).
Fields of papers citing papers by Craig E. Cole
This network shows the impact of papers produced by Craig E. Cole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig E. Cole. The network helps show where Craig E. Cole may publish in the future.
Co-authors
The 25 scholars most cited alongside Craig E. Cole, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 302 | |
| 2 | 2009 | 199 | |
| 3 | 2003 | 120 | |
| 4 | 2019 | 55 | |
| 5 | 2020 | 52 | |
| 6 | 2020 | 40 | |
| 7 | 2020 | 37 | |
| 8 | 2016 | 29 | |
| 9 | 2015 | 26 | |
| 10 | 2022 | 21 | |
| 11 | 2015 | 20 | |
| 12 | 2023 | 19 | |
| 13 | 2018 | 16 | |
| 14 | 2017 | 13 | |
| 15 | 2016 | 11 | |
| 16 | Preferences and Priorities for Relapsed Multiple Myeloma Treatments Among Patients and Caregivers in the United States | 2022 | 10 |
| 17 | 2008 | 8 | |
| 18 | 2024 | 7 | |
| 19 | 2016 | 7 | |
| 20 | 2015 | 6 |
About Craig E. Cole
Craig E. Cole is a scholar working on Hematology, Molecular Biology, Pathology and Forensic Medicine, Oncology and Genetics, having authored 48 papers that have together received 1.1k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (35 papers), Chronic Lymphocytic Leukemia Research (13 papers), Lymphoma Diagnosis and Treatment (9 papers), Protein Degradation and Inhibitors (6 papers), Peptidase Inhibition and Analysis (6 papers), Cancer Mechanisms and Therapy (5 papers), Cancer therapeutics and mechanisms (5 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Hematology (464 citations), Genetics (258 citations), Pathology and Forensic Medicine (403 citations), Oncology (444 citations) and Molecular Biology (384 citations). Craig E. Cole has collaborated with scholars based in United States, Greece and Canada. Frequent co-authors include Dennis Pietronigro, Glen R. Justice, Jerome B. Zeldis, Julie M. Vose, Kenichi Takeshita, Annette Ervin‐Haynes, Peter H. Wiernik, Thomas M. Habermann, Joseph M. Tuscano and Wwt Lam. Their work appears in journals such as Blood, Journal of Clinical Oncology, Blood Cancer Journal, Annals of Hematology and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.